Literature DB >> 25941172

Amino acid residues Leu135 and Tyr236 are required for RNA binding activity of CFIm25 in Entamoeba histolytica.

Juan David Ospina-Villa1, Absalom Zamorano-Carrillo2, Cesar Lopez-Camarillo3, Carlos A Castañon-Sanchez4, Jacqueline Soto-Sanchez5, Esther Ramirez-Moreno2, Laurence A Marchat6.   

Abstract

Pre-mRNA 3' end processing in the nucleus is essential for mRNA stability, efficient nuclear transport, and translation in eukaryotic cells. In Human, the cleavage/polyadenylation machinery contains the 25 kDa subunit of the Cleavage Factor Im (CFIm25), which specifically recognizes two UGUA elements and regulates the assembly of polyadenylation factors, poly(A) site selection and polyadenylation. In Entamoeba histolytica, the protozoan parasite responsible for human amoebiasis, EhCFIm25 has been reported as a RNA binding protein that interacts with the Poly(A) Polymerase. Here, we follow-up with the study of EhCFIm25 to characterize its interaction with RNA. Using in silico strategy, we identified Leu135 and Tyr236 in EhCFIm25 as conserved amino acids among CFIm25 homologues. We therefore generated mutant EhCFIm25 proteins to investigate the role of these residues for RNA interaction. Results showed that RNA binding activity was totally abrogated when Leu135 and Tyr236 were replaced with Ala residue, and Tyr236 was changed for Phe. In contrast, RNA binding activity was less affected when Leu135 was substituted by Thr. Our data revealed for the first time -until we know-the functional relevance of the conserved Leu135 and Tyr236 in EhCFIm25 for RNA binding activity. They also gave some insights about the possible chemical groups that could be interacting with the RNA molecule.
Copyright © 2015 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Cleavage factor Im; Entamoeba histolytica; Mutagenesis; Polyadenylation; RNA binding

Mesh:

Substances:

Year:  2015        PMID: 25941172     DOI: 10.1016/j.biochi.2015.04.017

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  8 in total

1.  Silencing the cleavage factor CFIm25 as a new strategy to control Entamoeba histolytica parasite.

Authors:  Juan David Ospina-Villa; Nancy Guillén; Cesar Lopez-Camarillo; Jacqueline Soto-Sanchez; Esther Ramirez-Moreno; Raul Garcia-Vazquez; Carlos A Castañon-Sanchez; Abigail Betanzos; Laurence A Marchat
Journal:  J Microbiol       Date:  2017-09-28       Impact factor: 3.422

2.  Importance of amino acids Leu135 and Tyr236 for the interaction between EhCFIm25 and RNA: a molecular dynamics simulation study.

Authors:  Juan David Ospina-Villa; Juan García-Contreras; Jorge Luis Rosas-Trigueros; Esther Ramírez-Moreno; César López-Camarillo; Beatriz Zamora-López; Laurence A Marchat; Absalom Zamorano-Carrillo
Journal:  J Mol Model       Date:  2018-07-12       Impact factor: 1.810

Review 3.  Life and Death of mRNA Molecules in Entamoeba histolytica.

Authors:  Jesús Valdés-Flores; Itzel López-Rosas; César López-Camarillo; Esther Ramírez-Moreno; Juan D Ospina-Villa; Laurence A Marchat
Journal:  Front Cell Infect Microbiol       Date:  2018-06-19       Impact factor: 5.293

4.  Unraveling the relevance of the polyadenylation factor EhCFIm25 in Entamoeba histolytica through proteomic analysis.

Authors:  América Itzallana Salgado-Martínez; Rodolfo Gamaliel Avila-Bonilla; Esther Ramírez-Moreno; Carlos Alberto Castañón-Sánchez; César López-Camarillo; Laurence A Marchat
Journal:  FEBS Open Bio       Date:  2021-09-13       Impact factor: 2.693

5.  Solid phase synthesis of TyrT, a thymine-tyrosine conjugate with poly(A) RNA-binding ability.

Authors:  Giovanni N Roviello; Valentina Roviello; Ida Autiero; Michele Saviano
Journal:  RSC Adv       Date:  2016-03-02       Impact factor: 3.361

6.  Targeting the polyadenylation factor EhCFIm25 with RNA aptamers controls survival in Entamoeba histolytica.

Authors:  Juan David Ospina-Villa; Alexandre Dufour; Christian Weber; Esther Ramirez-Moreno; Absalom Zamorano-Carrillo; Nancy Guillen; César Lopez-Camarillo; Laurence A Marchat
Journal:  Sci Rep       Date:  2018-04-09       Impact factor: 4.379

7.  CFIm25 inhibits hepatocellular carcinoma metastasis by suppressing the p38 and JNK/c-Jun signaling pathways.

Authors:  Yunwu Wang; Yu Xu; Wei Yan; Ping Han; Jingmei Liu; Jin Gong; Dongxiao Li; Xiangming Ding; Han Wang; Zhuoying Lin; Dean Tian; Jiazhi Liao
Journal:  Oncotarget       Date:  2018-01-31

Review 8.  Aptamers as a promising approach for the control of parasitic diseases.

Authors:  Juan David Ospina-Villa; Absalom Zamorano-Carrillo; Carlos A Castañón-Sánchez; Esther Ramírez-Moreno; Laurence A Marchat
Journal:  Braz J Infect Dis       Date:  2016-10-15       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.